Ophelia in plain terms: one condition, one medication class
Ophelia prescribes buprenorphine-naloxone for opioid use disorder over telehealth, with licensed clinicians running the evaluation and a pharmacy near you filling the prescription. Self-pay care starts at $245 a month, and the caveat travels with the figure: meds billed separately at pharmacy. The service also bills insurance, which swaps one predictable fee for copays, coinsurance and whatever your deductible has left to absorb. The scope is deliberately narrow, so alcohol, benzodiazepine and stimulant use disorders need a different provider entirely. Two trade-offs decide the fit: your monthly charge is not your total spend, and state coverage is limited enough that you should confirm your own state before you build a plan around it.
What the monthly fee buys, and what still lands on your bill
An honest Ophelia review starts with that split bill, because it is the single thing most people misread. The recurring charge pays for the clinical side of treatment: appointments with a prescriber and the prescribing work that follows. The medicine itself is a separate transaction, so your real outlay each month is the subscription plus your pharmacy’s charge for buprenorphine-naloxone.
The self-pay route
Flat monthly pricing has a genuine advantage in this category. Care costs the same in a busy month with an extra check-in as it does in a quiet one, so nothing stacks up per visit. The weakness is that nobody can hand you one all-in number until you know what your pharmacy charges. Generic buprenorphine-naloxone film and tablets are widely stocked, and cash prices vary between chains, so calling two pharmacies before you start is time well spent.
The insurance route
Because insurance billing is available, the same care can run through your plan instead. Ask two questions before you choose: whether Ophelia is in network with your specific plan in your state, and what your share of each visit would be once the claim is processed. Then ask your plan what tier buprenorphine-naloxone sits on, since medication moves through your pharmacy benefit rather than the subscription. Medicare covers opioid use disorder treatment services, and the official coverage page is listed in the sources at the end if you are on a Medicare plan.
| Route | How the clinical side bills | What to confirm first |
|---|---|---|
| Self-pay | Recurring flat monthly charge for care, billed by the provider | Whether the first month matches the ongoing rate, and the notice period for cancelling |
| Insurance | A claim filed to your plan, so your share follows copay, coinsurance and deductible rules | Network status for your plan and state, plus your pharmacy benefit for buprenorphine-naloxone |
What to confirm before the first charge
- Whether the opening month is billed at the same rate as every month after it.
- How many appointments the monthly fee includes, and what happens when you need more.
- Whether drug screens, lab work or letters for other clinicians carry their own charge.
- The cancellation notice period and the exact date your next payment lands.
- Your pharmacy’s cash price for the generic, if you are paying without a plan.
Work out the yearly picture on both routes before you commit, because the cheaper option on paper flips depending on your deductible. Our Free Savings Report lays the same maths out in one place.
Self-Pay vs. Insurance: What Changes
| Self-Pay | Insurance | |
|---|---|---|
| Clinical side billing | Flat monthly subscription | Copay, coinsurance, deductible rules |
| Medication billing | Cash price at pharmacy | Pharmacy benefit tier for buprenorphine-naloxone |
| Key thing to confirm first | First-month rate and cancellation notice period | Network status for your plan and state |
| Privacy on claims | No entry in claims history | Appears on explanation of benefits |
If you want to see the two routes head to head with your own numbers, run them here.
Insurance or cash pay, which is cheaper
Going through insurance is not automatically cheaper. Deductibles, copays and prior authorisation can make a cash-pay programme the better deal.
Coverage is never something a programme can promise: plans decide, prior authorisation is routine for GLP-1 medicines, and denials are common. Confirm with your own plan before choosing.
How buprenorphine-naloxone works, and what the first weeks feel like
What the medicine actually does
Buprenorphine is a partial opioid agonist. It binds tightly to the same receptors that heroin, fentanyl and oxycodone reach, which blunts withdrawal and cravings without producing the same high at treatment doses. That partial action also puts a ceiling on its effect on breathing compared with full agonists, one reason it is used outside a clinic setting. The naloxone in the combination product is poorly absorbed under the tongue and is there to discourage injecting the medicine.
Starting treatment and precipitated withdrawal
Timing the first dose is the delicate part. Started too soon after a full opioid agonist, buprenorphine can displace that drug and trigger precipitated withdrawal, which comes on fast and feels worse than waiting would have. Fentanyl makes the timing harder to judge than short-acting pills did, so this is a conversation for your prescriber, not a plan to improvise. Expect questions about what you used, how much and when, and expect the clinician to walk you through what to do if symptoms turn.
Side effects most people notice
Headache, nausea, constipation, sweating, trouble sleeping and numbness or soreness in the mouth are among the commonly reported effects. Dental problems, including tooth decay and cavities, have been reported with buprenorphine medicines that dissolve in the mouth, so rinsing with water after the dose fully dissolves and keeping up dental care both matter. Tell your prescriber if nausea or sleep problems persist past the first weeks rather than quietly stopping the medicine.
Serious warnings and interactions
Combining buprenorphine with benzodiazepines, alcohol or other sedatives raises the risk of dangerous breathing problems. The FDA has also been clear that clinicians should not simply withhold treatment for opioid use disorder from people who take benzodiazepines or other central nervous system depressants, and should instead manage the combination carefully, as set out in its safety communication on withholding opioid addiction medications. Liver injury has been reported, so be upfront about hepatitis, heavy alcohol use or existing liver disease. Never stop abruptly on your own: tolerance falls when treatment stops, and overdose risk rises with it, which is why a naloxone rescue kit belongs in the house from day one. If you are pregnant or planning to be, raise it at intake, because product choice and monitoring in pregnancy are individual clinical decisions and newborns can experience opioid withdrawal.
Monitoring and coordination with the rest of your care
Expect scheduled follow-up appointments, and ask at intake what monitoring the program uses: urine drug screening, prescription monitoring database checks, liver testing, and whether counselling or therapy is expected alongside the medicine. Ask who your other clinicians will hear from as well, since a primary care doctor prescribing sedatives or a dentist planning surgery both need to know you are on buprenorphine. General medication background sits in our Medication Guide Index if you want to read up before the call.
What the evidence supports, and what it does not
Buprenorphine maintenance has strong systematic-review support for keeping people in treatment and reducing illicit opioid use compared with placebo, and at adequate doses it performs comparably to methadone on retention. That evidence is about staying in care, not a guarantee about any one person’s outcome. Treatment length is individual, and stopping early is associated with returning to use, so ask how the program handles tapering conversations rather than assuming a fixed course.
What Ophelia does not treat
The narrow catalogue is a feature and a limit at the same time. Opioid use disorder is the whole business, so there is no thin second service line competing for clinician attention. That also means several common needs fall outside it.
- Methadone. Federal rules restrict methadone for opioid use disorder to licensed opioid treatment programs, so telehealth cannot substitute. If methadone is the right medicine for you, a certified program is the route.
- Alcohol, benzodiazepine and stimulant use disorders. These need different medicines and, for alcohol and benzodiazepines, sometimes medically supervised withdrawal, because unsupervised withdrawal from those drugs can be dangerous.
- Emergencies and acute medical care. Overdose, chest pain, severe withdrawal with vomiting and dehydration, or suicidal thoughts need urgent in-person help, not a scheduled video visit.
- Higher levels of care. Residential treatment, intensive outpatient programs and detox facilities all sit above what an outpatient telehealth service can deliver.
If the program offers any other medication for opioid use disorder, ask directly at intake which options are on the table and why the clinician recommends one over another.
Signing up: from first click to first prescription
Step 1: Confirm the service reaches your state
Clinicians can only treat patients in states where they hold a license, and coverage here is limited rather than nationwide. Confirm the state you are physically in is covered before you spend time on paperwork, and mention it if you split time between two states or are about to move.
Step 2: Book intake and gather your history
Have the practical details to hand: what you have been using and for how long, past treatment attempts, current prescriptions including any sedatives, other medical conditions, your insurance card if you are using a plan, and the pharmacy you want to use. Find a private space with a stable connection, since this conversation is detailed and personal.
Step 3: The clinician evaluation
A prescription for a controlled substance requires an evaluation by a licensed prescriber, and no telehealth service can skip that. Expect questions about your opioid use, mental health, pain history and living situation, then a plan for when and how to take the first dose. Ask what happens if the clinician decides telehealth is not the safe setting for you.
Step 4: The prescription reaches your pharmacy
Because medication bills at the pharmacy, the script goes to a local pharmacy rather than arriving as a shipment. Call ahead to confirm the pharmacy stocks the product and strength prescribed, since supply gaps are the most common cause of a delayed first dose. Ask what the counter price will be before you leave the house if you are paying cash.
Step 5: Follow-ups and the billing cycle
From there the pattern is scheduled follow-up appointments and prescriptions issued in line with them, with your subscription or insurance claim running in the background. Note the billing date in your calendar on day one. It is the number one thing people forget and the number one reason subscription care generates complaints.
Quick tip: Ask, in writing, how cancellation is submitted and how many days of notice it needs before your next charge.
Refills, follow-ups and reaching a human
Refills and pharmacy hiccups
Buprenorphine-naloxone is a Schedule III controlled substance, so prescriptions carry tighter rules than a blood pressure refill. That makes appointment timing consequential: a missed follow-up can mean a gap at the pharmacy. Ask how far ahead the next prescription is sent, what happens when your pharmacy is out of stock, and whether a script can be redirected to another pharmacy the same day.
When you need someone quickly
Before you rely on any telehealth program for ongoing controlled-substance care, get specifics on support: which channels exist, what hours they cover, how urgent messages are triaged, and who you reach on a weekend when a fill fails. Ask whether you see the same clinician each time or whoever is available, because continuity affects how quickly a dose problem gets sorted. If you are switching from another provider, ask both sides how records transfer so the new prescriber can see your history rather than starting from scratch.
Privacy, records and who can see your treatment
Records and federal protections
Substance use disorder treatment records carry extra federal protection beyond standard health privacy rules, which limits how they can be shared and used. That protection is real, but it does not cover everything a modern app collects. Read the notice of privacy practices and ask which parts of your account are clinical records and which are ordinary consumer app data.
What to ask about your data
- What information is collected beyond your medical record, including device and analytics data.
- Whether anything is shared with advertising or marketing partners.
- What appears on an insurance explanation of benefits if you use your plan, and who else in the household might see it.
- How to request a copy of your records, and how to request deletion of account data if you leave.
The insurance question matters more here than in most categories. Paying cash keeps treatment out of your claims history, which is a legitimate reason some patients pick the self-pay route even when a plan would cost less.
Trust and safety: the record behind the brand
Most people looking for an Ophelia review want the legitimacy question answered before anything else, so here it is plainly. The service holds LegitScript certification, an external compliance review that matters in online controlled-substance prescribing because it is one of the few third-party checks in the space. Care is delivered by licensed clinicians, and a prescription still requires an evaluation, which is exactly the boundary a scam operation ignores.
The moving part is federal policy. Telehealth prescribing rules for buprenorphine have been extended and revised repeatedly since the 2020 flexibilities began, so ask what the current requirements mean for you, including whether any in-person visit is expected during treatment. Pricing transparency is a point in the provider’s favour: a published cash monthly rate is more than many controlled-substance telehealth services offer, and the separate pharmacy cost is stated rather than buried. We score every provider the same way, and you can read the weights in How We Score Providers.
Our own coverage is desk research, and prices are re-checked against the provider’s live site on a schedule. Community reviews on our pages are moderated, incentivised reviews are labeled, and any sponsored placement is labeled and never changes a score or a rank.
Who Ophelia serves well, and who needs another door
This suits someone who wants buprenorphine-naloxone treatment without a clinic waiting room, has a pharmacy they can reach, and is stable enough for outpatient care by video and phone. It also suits people who value the discretion of paying cash at a flat rate, and people whose plan happens to be in network. The single-condition focus is a real strength if opioid use disorder is what you are treating.
Look elsewhere if methadone is your medicine, if you need medically supervised withdrawal, if you are dealing primarily with alcohol, benzodiazepine or stimulant use, or if your situation calls for residential or intensive outpatient care. Rule it out too if your state is not covered, if you have no private space or reliable connection for appointments, or if you need one bundled bill covering medication as well as care. Our Telehealth Provider Directory is the place to widen the search, and Editorial Coverage works through how these programs differ in practice.
Questions to ask before your first appointment
- What does the monthly charge include, and what is billed on top of it?
- How often will I see a prescriber, and can I message between appointments?
- What monitoring is required, and does anything about screens or labs cost extra?
- What is the plan if my pharmacy is out of stock or my prescription is delayed?
- Is counselling expected alongside the medicine, and is it arranged here or elsewhere?
- How do I cancel, how much notice do you need, and what refund terms apply?
Switching from another program adds three more: ask your current provider how it transfers records, how long your existing prescription covers you, and when cancelling stops the next charge without leaving a gap in treatment.
Then price the full year, subscription plus pharmacy cost, so the decision rests on a number rather than a monthly headline.
Questions to Ask Before Your First Appointment
- What does the monthly charge include, and what is billed on top?
- Is Ophelia in network with your specific plan in your state?
- What is your pharmacy's cash price for generic buprenorphine-naloxone?
- How far ahead is the next prescription sent to the pharmacy?
- What monitoring is required, and does anything about screens or labs cost extra?
- How do I cancel, how much notice is needed, and what refund terms apply?
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
Our Patient Cost Calculators are free to use if you want to run my numbers on paper before the call.
Reputation check: a name that hides the signal
Public sentiment here is unusually hard to search, because the brand shares its name with a Shakespeare character, a Lumineers song and a 2018 film. General searches surface literature and music, not patients, so ignore the noise and go to named sources instead.
Check the Better Business Bureau business profile for accreditation status and the pattern of formal complaints alongside the company’s responses. Then read the Apple App Store and Google Play listings for current ratings and recent written reviews. In subscription care the useful reading is never the average score: it is the low-star reviews and the provider’s replies, where the recurring themes tend to be billing after cancellation and appointment rescheduling. If those complaints exist and are answered promptly and specifically, that tells you more than a rating does.
We do not publish sentiment figures we cannot attribute to a named source, and we never present outside ratings as our own assessment.
Authoritative sources
- MedlinePlus patient information on buprenorphine for opioid dependence
- FDA information on medication treatment for opioid use disorder
- Cochrane review of buprenorphine maintenance for opioid dependence
- SAMHSA guidance on medications for substance use disorders
- MedlinePlus overview of opioid misuse and addiction
- LegitScript certification program
- Medicare coverage of opioid use disorder treatment services
Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.